Reflecting on the cardiac toxicity in non-small cell lung cancer in the era of immune checkpoint inhibitors therapy combined with thoracic radiotherapy-Reference-Cited by-同舟云学术

Reflecting on the cardiac toxicity in non-small cell lung cancer in the era of immune checkpoint inhibitors therapy combined with thoracic radiotherapy

Published:2023-11 Issue:6 Volume:1878 Page:189008
ISSN:0304-419X
Container-title:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer

Author:

Luo Yuxi,Zeng Zhimin,Liu Yunwei,Liu Anwen

Funder

Natural Science Foundation of Jiangxi Province

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Oncology

Reference173 articles.

1. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J. Clin. Oncol.,2010

2. Safety profile of nivolumab monotherapy: a pooled analysis of patients with advanced melanoma;Weber;J. Clin. Oncol.,2017

3. Fulminant myocarditis with combination immune checkpoint blockade;Johnson;N. Engl. J. Med.,2016

4. Immune checkpoint inhibitors and cardiovascular toxicity;Lyon;Lancet Oncol.,2018

5. Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases;Tison;Nat. Rev. Rheumatol.,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pembrolizumab and low-dose, single-fraction radiotherapy for patients with relapsed or refractory multiple myeloma: a prospective, single-centre, single-group, open-label, phase 2 pilot trial in the USA;The Lancet Haematology;2024-07

2. Serum IL‐24 combined with CA125 as screening and prognostic biomarkers for NSCLC;Cell Biology International;2024-05-15